UK Warns of Big Omicron Risk

December 9, 2021 Topic: Omicron Region: Europe Blog Brand: Coronavirus Tags: OmicronCoronavirusPandemicVaccinationBooster Shot

UK Warns of Big Omicron Risk

The UK Health Security Agency predicts that Omicron was likely to overtake Delta and become the dominant variant in that country. 

Ever since the Omicron variant first appeared around Thanksgiving, the U.S. government has been cautious but largely optimistic. While often caveating that we must remain vigilant and that much remains to be seen when it comes to data, most of the news so far has been good, on the U.S. side.

For instance, the head of the CDC said Thursday that most of the forty Omicron cases reported so far in the United States have been mild. There has yet to be a confirmed death from the new variant, in the United States. 

“When I look to what the future holds, so much of that is definitely about the science, but it’s also about coming together as a community to do things that prevent disease in yourself and one another,” CDC head Dr. Rochelle Walensky said an interview with the Associated Press. “And I think a lot of what our future holds depends on how we come together to do that.” 

However, it’s a different story in the UK. 

The UK Health Security Agency issued a risk assessment on Wednesday for the Omicron variant, giving scores of “Red,” the most serious status, for “growth advantage” and “immune evasion.” It gave the variant an “Amber” status for transmissibility. It reported “insufficient data” when it came to infection severity. 

The agency predicted that Omicron was likely to overtake Delta and become the dominant variant in that country. 

“The observed growth advantage may be due to immune evasion or transmissibility. It is most plausible that it is a combination of both,” according to the risk assessment. “The current growth rate implies either a substantial change in one parameter or at least moderate change in both (for example if transmissibility is similar to Delta, immune evasion must be substantial).” 

The risk assessment also called increased transmissibility, compared to that of Delta as “biologically plausible.” 

On immune evasion, the assessment stated that “the mutations present are very likely to reduce antibody binding and include changes in all 4 neutralising antibody binding sites in the RBD and also in antigenic sites in the spike N terminal domain.” 

The population in the United States has been warned to expect one million cases by the end of December, according to CNBC.

“If the growth rate and doubling time continue at the rate we have seen in the last 2 weeks, we expect to see at least 50% of coronavirus (COVID-19) cases to be caused by Omicron variant in the next 2 to 4 weeks,” the UKHSA said in a press statement this week. The question of transmissibility, and whether it is worse than previous variants, continues to be studied by scientists in the UK.

Stephen Silver, a technology writer for the National Interest, is a journalist, essayist and film critic, who is also a contributor to The Philadelphia Inquirer, Philly Voice, Philadelphia Weekly, the Jewish Telegraphic Agency, Living Life Fearless, Backstage magazine, Broad Street Review and Splice Today. The co-founder of the Philadelphia Film Critics Circle, Stephen lives in suburban Philadelphia with his wife and two sons. Follow him on Twitter at @StephenSilver. 

Image: Reuters